Title: Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities
Authors: Medina, Reinhold J
O'Neill, Christina L
Sweeney, Mark
Guduric-Fuchs, Jasenka
Gardiner, Tom A
Simpson, David A
Stitt, Alan W
Issue Date: 13-May-2010
Abstract: Abstract Background The term endothelial progenitor cells (EPCs) is currently used to refer to cell populations which are quite dissimilar in terms of biological properties. This study provides a detailed molecular fingerprint for two EPC subtypes: early EPCs (eEPCs) and outgrowth endothelial cells (OECs). Methods Human blood-derived eEPCs and OECs were characterised by using genome-wide transcriptional profiling, 2D protein electrophoresis, and electron microscopy. Comparative analysis at the transcript and protein level included monocytes and mature endothelial cells as reference cell types. Results Our data show that eEPCs and OECs have strikingly different gene expression signatures. Many highly expressed transcripts in eEPCs are haematopoietic specific (RUNX1, WAS, LYN) with links to immunity and inflammation (TLRs, CD14, HLAs), whereas many transcripts involved in vascular development and angiogenesis-related signalling pathways (Tie2, eNOS, Ephrins) are highly expressed in OECs. Comparative analysis with monocytes and mature endothelial cells clusters eEPCs with monocytes, while OECs segment with endothelial cells. Similarly, proteomic analysis revealed that 90% of spots identified by 2-D gel analysis are common between OECs and endothelial cells while eEPCs share 77% with monocytes. In line with the expression pattern of caveolins and cadherins identified by microarray analysis, ultrastructural evaluation highlighted the presence of caveolae and adherens junctions only in OECs. Conclusions This study provides evidence that eEPCs are haematopoietic cells with a molecular phenotype linked to monocytes; whereas OECs exhibit commitment to the endothelial lineage. These findings indicate that OECs might be an attractive cell candidate for inducing therapeutic angiogenesis, while eEPC should be used with caution because of their monocytic nature.
Description: RIGHTS : This article is licensed under the BioMed Central licence at http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'. In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.
URI: http://www.dspace.cam.ac.uk/handle/1810/237830
Other Identifiers: http://dx.doi.org/10.1186/1755-8794-3-18
Appears in Collections:Caa-BioMed - No Cambridge University Affiliation

Files in This Item:

File Description SizeFormat
1755-8794-3-18.xml80.54 kBXMLView/Open
1755-8794-3-18-S3.MPG104 kBMPEGView/Open
1755-8794-3-18-S2.MPG106 kBMPEGView/Open
1755-8794-3-18-S5.MPG68 kBMPEGView/Open
1755-8794-3-18.pdf3.92 MBAdobe PDFThumbnail
View/Open
1755-8794-3-18-S1.DOCX242.53 kBZIPView/Open
1755-8794-3-18-S4.MPG84 kBMPEGView/Open
Additional resources for this item
search for alternative versions in eresources@cambridge
retrieve citation metadata in EndNote format

This item has been accessed 221 times.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.